
Number of publications published per year by Seki, Ekihiro. (Source : PubMed)

Distribution of publications types for Seki, Ekihiro. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Toll-like receptor 9 Promotes Steatohepatitis via Induction of Interleukin-1beta in Mice.
Gastroenterology
2010

Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis.
Proc. Natl. Acad. Sci. U.S.A.
2010;107;2
Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice.
Hepatology
2010;51;1


c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice.
Gastroenterology
2009;137;4

Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.
Hepatology
2009;50;3

[Video-assisted thoracic surgery for pulmonary metastasis of colorectal cancer]
Gan To Kagaku Ryoho
2009;36;8

CCR1 and CCR5 promote hepatic fibrosis in mice.
J. Clin. Invest.
2009;119;7

CCR2 promotes hepatic fibrosis in mice.
Hepatology
2009;50;1

Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog.
Proc. Natl. Acad. Sci. U.S.A.
2009;106;5

Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells.
Hepatology
2008;48;6
[ See timeline ] [ See all publications ]
means that Seki, Ekihiro has 16 papers cited a least 16 times - methodology
University of California San Diego, School of Medicine, San Diego, CA 92093-0602, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.